Gastric Cancer Testing Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Gastric Cancer Testing Market: By Test (Immunohistochemistry (IHC), Fluorescent in situ hybridization (FISH)), By Product (Kits and Reagents), By Gastric Cancer type (Adenocarcinoma, Lymphoma, Gastrointestinal stromal tumor (GIST), and Carcinoid Tumor), By End User (Hospitals, Diagnostic Centers, and Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global gastric cancer testing market expected to grow at 5% Compound Annual Growth Rate (CAGR) over 2020 to 2027. Cancer begins in the body when the cells in the body grow without any control. Cells present in any part of the body can develop cancer, which tend to spread to the other parts of the body. Gastric cancer is a type of cancer that starts in the stomach. The gastric cancer is also called as the stomach cancer. The progression of this cancer is slow. The advancement in the growth of the tumor leads serious complications. The treatment depends on the stage of the cancer. The early diagnosis helps in improving the survival rates. Cancer is caused by uncontrolled abnormal cell proliferation that has the ability to spread and invade other sections of the body. Changes in the gene cause a single cell or a few cells to expand and replicate, which is when cancer begins. This could lead to the growth of a tumour, which is an abnormal mass of tissue. The creation of cancer cells in the stomach lining is known as gastric cancer or stomach cancer. Diet and stomach disorders are both risk factors for gastric cancer. Indigestion and stomach pain or discomfort are signs of gastric cancer. The global gastric cancer testing market is expected to develop due to an increase in the incidence of gastrointestinal tumours, lymphoma, and adenocarcinoma, as well as an increase in alcohol use, smoking, and the geriatric population. However, the global gastric cancer testing market is expected to be hampered by tight government regulations and high testing costs.

Gastric Cancer Testing Market

MARKET SUMMARY
-
5% CAGR
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 5%
  • Largest Market– Asia Pacific
  • Fastest Growing Market– North America

Gastric Cancer Testing Market

  • The report on global Gastric Cancer Testing Market gives historical, current, and future market sizes (US$ Bn) on the basis of test, product, gastric cancer type, end user and geography.
  • Gastric Cancer Testing Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Agilent Technologies, Inc. (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Illumina, Inc. (Denmark)
  • Becton, Dickinson and Company (U.S.)
  • GE Healthcare (U.K.)
Dynamics

Gastric Cancer Testing Market

Increase in the prevalence of gastrointestinal tumors, adenocarcinoma, lymphoma etc. and change in the lifestyles are majorly driving the growth of the gastric cancer testing market. Various factors such as increasing alcohol consumption and smoking is anticipated to drive the growth of the gastric cancer testing market. However, the stringent government regulations for the approval would hamper the growth of the market. The high cost involved in the testing would restrain the growth of the gastric cancer testing market.


Asia-Pacific got significant share

Gastric Cancer Testing Market

Geographically, global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Asia Pacificgastric cancer testing market is the dominant market when compared with that of the other regional markets. According to the World Cancer Research Fund International, Japan has held the largest share of around 24.7% in the global stomach cancer treatment market owing to its higher consumption of the spicy and salty food. Also, the other countries such as China which accounted for about 29.9% and South Korea which accounted for 41.4% has higher rates of incidence in the stomach cancer. According to the World Health Organization (WHO), there are 723,000 cancer related deaths caused by the stomach cancer all across the globe. The North America and the European region are expected to grow at slow pace over the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Gastric Cancer Testing Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Agilent Technologies, Inc. (U.S.)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Illumina, Inc. (Denmark)
  • Becton, Dickinson and Company (U.S.)
  • GE Healthcare (U.K.)
  • QIAGEN N.V. (Netherlands)
  • Abbott Laboratories, Inc. (U.S.)
  • Roche Diagnostics (Switzerland)
  • Siemens Healthcare (Germany)
  • Philips Healthcare (U.K.)
  • R. Bard, Inc. (U.S.)

Description

Global gastric cancer testing market expected to grow at 5% Compound Annual Growth Rate (CAGR) over 2020 to 2027. Cancer begins in the body when the cells in the body grow without any control. Cells present in any part of the body can develop cancer, which tend to spread to the other parts of the body. Gastric cancer is a type of cancer that starts in the stomach. The gastric cancer is also called as the stomach cancer. The progression of this cancer is slow. The advancement in the growth of the tumor leads serious complications. The treatment depends on the stage of the cancer. The early diagnosis helps in improving the survival rates. Cancer is caused by uncontrolled abnormal cell proliferation that has the ability to spread and invade other sections of the body. Changes in the gene cause a single cell or a few cells to expand and replicate, which is when cancer begins. This could lead to the growth of a tumour, which is an abnormal mass of tissue. The creation of cancer cells in the stomach lining is known as gastric cancer or stomach cancer. Diet and stomach disorders are both risk factors for gastric cancer. Indigestion and stomach pain or discomfort are signs of gastric cancer. The global gastric cancer testing market is expected to develop due to an increase in the incidence of gastrointestinal tumours, lymphoma, and adenocarcinoma, as well as an increase in alcohol use, smoking, and the geriatric population. However, the global gastric cancer testing market is expected to be hampered by tight government regulations and high testing costs.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX